Curis
CRIS
#11124
Rank
NZ$4.75 M
Marketcap
NZ$1.96
Share price
0.89%
Change (1 day)
-30.87%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2026 (TTM): NZ-$40.19

According to Curis's latest financial reports the company's current EPS (TTM) is NZ-$41.33. In 2025 the company made an earnings per share (EPS) of NZ-$41.33 an increase over its 2024 EPS that were of NZ-$244.15.

EPS history for Curis from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$40.19-2.76%
2025NZ-$41.33-83.07%
2024NZ-$244.15-22.15%
2023NZ-$313.61-26.17%
2022NZ-$424.7522.3%
2021NZ-$347.30-25.37%
2020NZ-$465.38-30.93%
2019NZ-$673.76-2.02%
2018NZ-$687.65
2016NZ-$1,563-10%
2015NZ-$1,737138.1%
2014NZ-$729.3340%
2013NZ-$520.95-25%
2012NZ-$694.6066.67%
2011NZ-$416.76

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
NZ$2.27-105.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$6.18-114.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
NZ-$0.63-98.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
NZ$5.44-113.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
NZ-$7.40-82.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
NZ-$8.75-78.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ-$0.30-99.29%๐Ÿ‡บ๐Ÿ‡ธ USA